Huaren Pharmaceutical Co Ltd
SZSE:300110
Wall Street
Price Targets
Price Targets Summary
Huaren Pharmaceutical Co Ltd
According to Wall Street analysts, the average 1-year price target for Huaren Pharmaceutical Co Ltd is 15.25 CNY .
Operating Income
Forecast
Operating Income Estimate
Huaren Pharmaceutical Co Ltd
For the last 8 years the compound annual growth rate for Huaren Pharmaceutical Co Ltd's operating income is 17%. The projected CAGR for the next 8 years is -13%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Huaren Pharmaceutical Co Ltd's stock price target?
Price Target
15.25
CNY
According to Wall Street analysts, the average 1-year price target for Huaren Pharmaceutical Co Ltd is 15.25 CNY .
What is Huaren Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
-4%
For the last 8 years the compound annual growth rate for Huaren Pharmaceutical Co Ltd's revenue is 5%. The projected CAGR for the next 8 years is -4%.
What is Huaren Pharmaceutical Co Ltd's Operating Income forecast?
Projected CAGR
-13%
For the last 8 years the compound annual growth rate for Huaren Pharmaceutical Co Ltd's operating income is 17%. The projected CAGR for the next 8 years is -13%.
What is Huaren Pharmaceutical Co Ltd's Net Income forecast?
Projected CAGR
-24%
For the last 8 years the compound annual growth rate for Huaren Pharmaceutical Co Ltd's net income is 30%. The projected CAGR for the next 7 years is -24%.